Index [chapter]

2014 Hemostasis and Thrombosis  
AAV8-FVIIa (gene therapy), 103 abatacept, 105 abciximab, 229-230 acidocalcisomes, 237 acquired hemophilia, 93-111, 267 clinical manifestations, 95 investigational agents, 102-103 laboratory tests, 95-97 relapse, 101-102 treatment, 97-101 activated coagulation factors factor V binding, 24 complex with factor Xa, 7 factor VII see recombinant activated factor VII factor VIII binding, 24 complex with factor IXa, 6 factor X, 5, 6-7, 24, see also anti-Xa test complex with factor Va, 7 factor XI
more » ... r XIa), 72-73 activated partial thromboplastin time (aPTT), 8-9, 32-33 acquired hemophilia, 96 circulating anticoagulants, 34-35 hemophilia B, 61 hemophilia C, 76 liver disease, 273 lupus anticoagulant, 35 sample storage, 31 activated protein C concentrates, 163 resistance (APC-R), 39-40 screening tests, 39-40 activated prothrombin complex concentrates, 53 acquired hemophilia, 98
doi:10.1002/9781118833391.index fatcat:rgc3wiuudjeazb45me4ncg6qxi